98%
921
2 minutes
20
The annual prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Malaysia has been estimated to be 30 % to 40 % of all S. aureus infections. Nevertheless, data on the antimicrobial resistance and genetic diversity of Malaysian MRSAs remain few. In 2009, we collected 318 MRSA strains from various wards of our teaching hospital located in Kuala Lumpur, the capital city of Malaysia, and performed antimicrobial susceptibility testing on these strains. The strains were then molecularly characterized via staphylococcal cassette chromosome (SCC) mec and virulence gene (cna, sea, seb, sec, sed, see, seg, seh, sei, eta, etb, Panton-Valentine leukocidin and toxic shock syndrome toxin-1) typing; a subset of 49 strains isolated from the intensive care unit was also typed using PFGE. Most strains were found to be resistant to ciprofloxacin (92.5 %), erythromycin (93.4 %) and gentamicin (86.8 %). The majority (72.0 %) of strains were found to harbour SCCmec type III-SCCmercury with the presence of ccrC, and carried the sea+cna gene combination (49.3 %), with cna as the most prevalent virulence gene (94.0 %) detected. We identified four PFGE clusters, with pulsotype C (n=19) as the dominant example in the intensive care unit, where this pulsotype was found to be associated with carriage of SCCmec type III and the sea gene (P=0.05 and P=0.02, respectively). In summary, the dominant MRSA circulating in our hospital in 2009 was a clone that was ciprofloxacin, erythromycin and gentamicin resistant, carried SCCmec type III-SCCmercury with ccrC and also harboured the sea+cna virulence genes. This clone also appears to be the dominant MRSA circulating in major hospitals in Kuala Lumpur.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1099/jmm.0.000387 | DOI Listing |
J Glob Antimicrob Resist
September 2025
Department of Medical Microbiology, University of Ghana Medical School, P. O. Box KB 4236, Korle Bu, Accra, Ghana. Electronic address:
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most pervasive pathogens, accounting for more deaths annually than some major infectious diseases. Its clinical significance lies not only in the ever-expansion of its antimicrobial resistance spectrum, but also its evolving clonal structure. In this systematic review and meta-analysis, we aimed to quantify mortality associated with MRSA clones and evaluate the contribution of specific molecular features to outcome variation.
View Article and Find Full Text PDFInt J Immunopathol Pharmacol
August 2025
Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Objective: This study aims to analyze isolates from pediatric cancer patients, determine the prevalence of PVL genes and assess their clinical implications.
Introduction: Methicillin-resistant infections pose significant challenges in pediatric oncology settings. Understanding the prevalence, genotypic characteristics, and antibiotic resistance patterns of aids in improving patients' outcomes.
J Infect Dis
August 2025
Department of Molecular Biosciences, University of South Florida, Tampa, FL, USA.
Background: One of the most successful and widely-distributed hospital-associated lineages of MRSA is clonal complex 5 (CC5). These strains are known for widespread antibiotic resistance, but less severe disease than CA-MRSA counterparts. Recently, CC5 descendant lineages have appeared globally with hypervirulent properties.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
Jiangsu Key Lab of Zoonosis/Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China.
Introduction: The CRISPR-Cas system serves as a defense mechanism in bacteria and archaea, protecting them against the invasion of mobile genetic elements. , a Gram-positive bacterium that diverged from , is characterized by the rare presence of the CRISPR-Cas system in only a few isolates.
Methods: In this study, we analyzed the prevalence of the type III-A CRISPR-Cas system in 368 genome sequences from animals, food sources, and humans across 26 countries, available in public database.
Int J Infect Dis
August 2025
Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Daptomycin has been used globally since 2003, with a corresponding increase in daptomycin nonsusceptible (DNS) Staphylococcus aureus. In South Korea, daptomycin became available in 2020, but emerging resistance has posed early therapeutic challenges. We observed suspected heteroresistance to daptomycin (h-DAP) in community-acquired methicillin-resistant S.
View Article and Find Full Text PDF